Literature DB >> 18355929

Development and validation of a duplex real-time PCR assay for the simultaneous detection and quantification of porcine circovirus type 2 and an internal control on porcine semen samples.

N Pal1, Y W Huang, D M Madson, C Kuster, X J Meng, P G Halbur, T Opriessnig.   

Abstract

A duplex real-time quantitative PCR (qPCR) method for the simultaneous detection of porcine circovirus type 2 (PCV2) and an exogenous internal positive control (IPC) in porcine semen samples was developed. The IPC was included to monitor DNA extraction and PCR inhibition and consisted of a mutated PCV2 plasmid clone which differed from the target PCV2 in the probe binding region and thus was detected by the use of a second probe with different end-labeling. The sensitivity, specificity and repeatability of the assay were validated by testing semen samples from 12 boars inoculated experimentally with PCV2, 10 boars infected naturally with PCV2, and 3 PCV2 negative control boars. The duplex qPCR assay was found to be more sensitive, specific, rapid, and repeatable than nested PCR (nPCR) methods for the detection of PCV2 DNA in semen. Analysis of separated semen fractions by the duplex qPCR assay showed PCV2 DNA to be present mainly in the cell fraction as opposed to the seminal plasma fraction which is in contrast to previous reports. The duplex qPCR assay was found to be a valuable tool for accurate and quantitative detection of PCV2 DNA in boar semen.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18355929     DOI: 10.1016/j.jviromet.2008.02.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  7 in total

1.  Effects of an inactivated porcine circovirus type 2 (PCV2) vaccine on PCV2 virus shedding in semen from experimentally infected boars.

Authors:  Hwi Won Seo; Kiwon Han; Duyeol Kim; Yeonsu Oh; Ikjae Kang; Changhoon Park; Hyun Jang; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero.

Authors:  D M Madson; A R Patterson; S Ramamoorthy; N Pal; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

3.  Evidence of porcine epidemic diarrhea virus (PEDV) shedding in semen from infected specific pathogen-free boars.

Authors:  Sarah Gallien; Angélique Moro; Gérald Lediguerher; Virginie Catinot; Frédéric Paboeuf; Lionel Bigault; Mustapha Berri; Phillip C Gauger; Nathalie Pozzi; Edith Authié; Nicolas Rose; Béatrice Grasland
Journal:  Vet Res       Date:  2018-01-24       Impact factor: 3.683

4.  Surveillance for respiratory and diarrheal pathogens at the human-pig interface in Sarawak, Malaysia.

Authors:  Laura K Borkenhagen; Kerry A Mallinson; Rick W Tsao; Siaw-Jing Ha; Wei-Honn Lim; Teck-Hock Toh; Benjamin D Anderson; Jane K Fieldhouse; Sarah E Philo; Kuek-Sen Chong; William G Lindsley; Alejandro Ramirez; James F Lowe; Kristen K Coleman; Gregory C Gray
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

5.  A feasibility study of conducting surveillance for swine pathogens in slurry from North Carolina swine farms.

Authors:  Emily S Bailey; Laura K Borkenhagen; Jessica Y Choi; Annette E Greer; Marie R Culhane; Gregory C Gray
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

6.  Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars.

Authors:  Darin M Madson; Sheela Ramamoorthy; Chris Kuster; Narinder Pal; Xiang-Jin Meng; Patrick G Halbur; Tanja Opriessnig
Journal:  Vet Res       Date:  2008-10-31       Impact factor: 3.683

7.  Limited shedding of an S-InDel strain of porcine epidemic diarrhea virus (PEDV) in semen and questions regarding the infectivity of the detected virus.

Authors:  Sarah Gallien; Angélique Moro; Gérald Lediguerher; Virginie Catinot; Frédéric Paboeuf; Lionel Bigault; Phillip C Gauger; Nathalie Pozzi; Mustapha Berri; Edith Authié; Nicolas Rose; Béatrice Grasland
Journal:  Vet Microbiol       Date:  2018-10-11       Impact factor: 3.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.